Author:
Smal M. P.,Nikitchenko N. V.,Rolevich A. I.,Nabebina T. I.,Krasny S. A.,Goncharova R. I.
Abstract
Promoter hypermethylation of tumor suppressor genes is one of the mechanisms of epigenetic regulation disturbance of gene expression and is often observed in different cancer types. The profile of mutational and epigenetic changes characterizes a malignant potential of a tumor, as well as its ability to invade and metastasize.The aim of the study was to determine a prognostic value of p16, p14ARF and TIMP3 gene methylation in the group of 158 bladder cancer patients. Epigenetic changes in these genes were observed with a frequency of 11.4, 0 and 10.8 %, respectively, and did not depend on clinic-morphological characteristics.A statistically significant association of p16 and TIMP3 abnormal methylation with smoking was found, indicating a possible influence of tobacco smoke carcinogens on the occurrence of these epigenetic changes. In the multivariate Cox regression analysis, p16 promoter hypermethylation was an independent predictor for bladder cancer progression (HR 6.84; 95 % CI 1.6–29.9; р = 0.011).The use of the data on the p16 methylation status may improve the accuracy of prognosis of the bladder cancer clinical course and the selection of appropriate treatment strategy.
Publisher
Publishing House Belorusskaya Nauka
Reference36 articles.
1. Okeanov A. E., Moiseev P. I., Levin L. F. Statistics of cancer diseases in the Republic of Belarus (2004–2013). Minsk, Republican Scientific and Practical Center of Oncology and Medical Radiology, 2014. 382 p. (in Russian).
2. Sylvester R. J., van der Meijden A. P., Oosterlinck W., Witjes J. A., Bouffioux C., Denis L., Newling D. W., Kurth K. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. European Urology, 2006, vol. 49, no. 3, pp. 466–477. https://doi. org/10.1016/j.eururo.2005.12.031
3. Esteller M. Epigenetic gene silencing in cancer:the DNA hypermethylome. Human Molecular Genetics, 2007, vol. 16, no. R1, pp. R50–R59. https://doi.org/10.1093/hmg/ddm018 4. Jones P. A., Baylin S. B. The epigenomics of cancer. Cell, 2007, vol. 128, no. 4, pp. 683–692. https://doi.org/ 10.1016/j. cell.2007.01.029
4. Enokida H., Nakagawa M. Epigenetics in bladder cancer. International Journal of Clinical Oncology, 2008, vol. 13, no. 4, pp. 298–307. https://doi.org/10.1007/s10147-008-0811-1
5. Neuhausen A., Florl A. R., Grimm M. O., Schulz W. A. DNA methylation alterations in urothelial carcinoma. Cancer Biology and Therapy, 2006, vol. 5, no. 8, pp. 993–1001.